Veterinary Medicines Information website

Tribex 100 mg/ml Oral Suspension for Cattle

Authorised
  • Triclabendazole
Download as PDF

Product identification

Medicine name:
Tribex 100 mg/ml Oral Suspension for Cattle
Active substance:
  • Triclabendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Triclabendazole
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        56
        day
      • Milk
        84
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Pack sizes:7.5L pack consisting of 2.5L & 5L packsContainer: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:5L pack contains 5L of productContainer: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:2.5L pack contains 2.5L of product,Container: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:2.5L pack contains 2.2L of product,Container: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:1L pack contains 0.8L of product,Container: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10003
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0130/001
Concerned member states:
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 7/06/2026
Download
Dutch (PDF)
Published on: 26/01/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 7/06/2026
Download